Tag: antibodies
Bio-Rad introduces anti-cemiplimab antibodies
These ready-made antibodies are suitable for developing selective and sensitive assays for bioanalysis and drug monitoring of cemiplimab
Bio-Rad introduces anti-daratumumab antibodies
These highly specific and high-affinity recombinant antibodies are suitable for bioanalysis and drug monitoring of daratumumab and its biosimilars
SMART develops 10-minute test for detection of COVID immunity
Newly developed paper-based blood test by researchers from Singapore-MIT Alliance for Research and Technology (SMART) can determine the presence of SARS-CoV-2 neutralizing antibodies within 10 minutes. This point-of-care test offers an accuracy rate of up to 93%..............................
Inflammation: Preventing the Good, Dealing with the Bad
Inflammation becomes a problem when our immune system stays on guard unnecessarily, and worst is when it is not just patrolling, but starts firing too, writes Dr Anju Dave Vaish.........................
J Mitra launches India’s first Covid-19 neutralizing antibody test
Covid-19 Neutralizing Antibody Microlisa Elisa Test is the first commercial laboratory test to detect neutralizing antibodies against SARS-CoV-2, the virus that causes Covid-19......................
Demystifying Covid vaccinations: Expert answers common questions
Padma Shree Presidential Awardee and Dr B. C. Roy Presidential Awardee, Doctor Sanjeev Bagai addresses some of the lingering questions around Covid-19 vaccination.......................
Time is a critical factor in plasma collection post COVID-19 recovery:...
In a new study, researchers report that antibody levels in the blood of COVID-19 patients drop rapidly during the weeks after their bodies have cleared the virus and symptoms have subsided............................
CSIR-CDRI conducts serological testing for antibodies against SARS-CoV-2
CSIR-CDRI is carrying out a research study that involves testing of people for antibodies against SARS-CoV-2. The serological testing was conducted from 9th-11th September.........................
COVID-19: India bets big on monoclonal antibodies amid mega industry &...
CSIR through its NMITLI program approves a multi institutional project to develop human monoclonal antibodies (hmAbs) that can neutralize SARS-CoV-2 in patients. The project will be implemented by National Centre for Cell Science (NCCS), IIT-Indore and PredOmix Technologies with Bharat Biotech International, as the commercialization partner...........................
COVID-19: A new diagnostic kit promises to detect infection in four...
A kit under development by the researchers at Rajiv Gandhi Centre for Biotechnology (RGCB), Thiruvananthapuram promises to help detect SARS CoVID-19 infection as early as four days post-infection of the virus...................